NCT02121860: PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers |
|
|
| Completed | 1 | 37 | US | IDN-6556, emricasan, PF-03491390 | Conatus Pharmaceuticals Inc. | Hepatic Impairment, Liver Diseases, Digestive System Diseases | 07/14 | 07/14 | | |
